The Fevertree share price hits 2-year peaks following a fresh update

The Fevertree Drinks share price has just sailed to new multi-year highs. Here are the key points from the UK share’s latest financials.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

The Fevertree Drinks (LSE: FEVR) share price has been on a roll in recent months. A fresh spurt upwards has taken gains over the past 12 months to a chubby 51%. UK share investors have piled in again on Thursday following the release of full-year financials.

At £26.90 per share, the share price is trading 5% higher today. It struck two-year peaks of £27.09 earlier in Thursday trading.

Fevertree share price rises as sales soar

In today’s update, Fevertree advised that it continued to enjoy robust demand at the beginning of 2021.

The company said that the performance of its off-trade channel had “remained strong” during the first four months of 2021. In the UK, sales were up 10.1% year-on-year during the 13 weeks to 18 April. This is even though the period overlapped the first Covid-19 lockdown of 2020 when huge customer stockpiling was taking place.

Fevertree said that sales of its premium mixers continued to grow ahead of the broader market in the period to mid-April. It’s a performance that it said indicates “the strength of the brand, the success of the new flavours and formats which we launched last year, and the marketing campaigns we have continued to invest in.”

A selection of bottles from Fevertree Drinks

Making progress overseas

Fevertree’s soaring share price today was also helped by news of stratospheric sales growth in its foreign marketplaces.

In the US, off-trade sales ballooned 38.2% year-on-year during the 12 weeks to 27 March. Fevertree said that turnover rocketed due to “increased at-home consumption” as well as an increase in trial and repeat purchases following price optimisation steps taken last year.

The company noted as well that it continues to make “encouraging progress” in its European off-trade market. It said that it has continued to build “on the strong sales and value share gains during 2020 across key markets” there. Elsewhere, Fevertree lauded the “strong progress” it continues to make in Australia’s off-trade market. And the firm said that it has seen “a good recovery in suburban areas” for its on-trade operations. The company continues to perform strongly in Canada, it said.

A bright outlook

Fevertree said that it expects off-trade sales to transition to on-trade as coronavirus restrictions are rolled back and the hospitality sector reopens. But it added that “it is clear that at-home consumption of long mixed drinks is becoming increasingly established, supported by both the retailers and spirit companies.”

The beverages giant added that while “reopening is going to vary between markets, our brand strength and the relationships we have with our on-trade partners makes us well placed to benefit from [the] return over the rest of the year.”

City analysts think annual earnings at Fevertree will rise 18% in 2021. This leaves the company trading on a forward price-to-earnings (P/E) ratio of 64 times. Another 29% bottom-line rise is predicted for 2022.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended Fevertree Drinks. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »